NCT00504803View on ClinicalTrials.gov

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Hematological Malignancies
Interventions
PROCEDURE

Mesenchymal stem cell infusion

Infusion of mesenchymal stem cells on the same day as hematopoietic stem cell infusion.

Trial Locations (1)

4000

CHU Sart Tilman, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT00504803 - Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease | Biotech Hunter | Biotech Hunter